|
|
|
Volumn 27, Issue 6 SUPPL. 12, 2000, Pages 25-29
|
|
Rituximab as first-line systemic therapy for patients with low-grade lymphoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRONCHODILATING AGENT;
CYCLOPHOSPHAMIDE;
DIPHENHYDRAMINE;
DOXORUBICIN;
MONOCLONAL ANTIBODY;
PARACETAMOL;
PETHIDINE;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
BONE MARROW TOXICITY;
BRONCHOSPASM;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CHILL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG HYPERSENSITIVITY;
DRUG INDUCED DISEASE;
FEMALE;
FEVER;
HUMAN;
LYMPHOMA;
MALE;
MULTICENTER STUDY;
NONHODGKIN LYMPHOMA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LYMPHOMA;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
|
|
EID: 0034469518
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (31)
|
|
References (10)
|
